Ken Griffin Dyadic International Inc Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$1.04 - $1.55 $9,568 - $14,260	9,200 Added 80.7%	20,600 $21,000
Q2 2024 Aug 14, 2024	BUY	$1.39 - $2.27 $14,177 - $23,154	10,200 Added 850.0%	11,400 $16,000
Q1 2024 May 15, 2024	SELL	$1.29 - $1.67 $42,054 - $54,442	-32,600 Reduced 96.45%	1,200 $2,000
Q4 2023 Feb 14, 2024	SELL	$1.52 - $2.04 $1,824 - $2,448	-1,200 Reduced 3.43%	33,800 $54,000
Q3 2023 Nov 14, 2023	SELL	$1.71 - $2.08 $15,219 - $18,512	-8,900 Reduced 20.27%	35,000 $67,000
Q2 2023 Aug 14, 2023	BUY	$1.56 - $2.38 $15,756 - $24,038	10,100 Added 29.88%	43,900 $84,000
Q1 2023 May 15, 2023	SELL	$1.25 - $1.86 $101,500 - $151,032	-81,200 Reduced 70.61%	33,800 $60,000
Q4 2022 Feb 14, 2023	SELL	$1.18 - $2.32 $1,888 - $3,711	-1,600 Reduced 1.37%	115,000 $141,000
Q3 2022 Nov 14, 2022	SELL	$1.65 - $3.42 $9,900 - $20,520	-6,000 Reduced 4.89%	116,600 $223,000

4.77M

20.6K

Ticker DYAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,423,100
Market Cap $55.7M
Description
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.